The most commonly used prostate cancer screening procedure, PSA, is at the center of a growing debate after its discoverer said it had become a "hugely expensive public health disaster." In a commentary in The New York Times, Richard Ablin of the University of Arizona said the screening tool he discovered four decades ago now costs too much and is ...

Too much cancer screening, too many heart tests, too many cesarean sections. A spate of recent reports suggests that many Americans are being overtreated. Maybe even President Barack Obama, champion of an overhaul and cost-cutting of the health care system. Is it doctors practicing defensive medicine? Or are ...

Recent reports and guideline changes suggest some medical tests should be delayed, avoided, or done less often: _ MAMMOGRAM: Most women don't need a mammogram in their 40s and they should get one every two years starting at 50, according to the U.S. Preventive Services ...

Pfizer Inc. said Thursday the cancer drug Sutent did not meet key goals in two late-stage studies focusing on advanced breast cancer. The drug is already sold as a treatment for advanced kidney cancer and gastrointestinal stromal cancer, which affects the stomach. Both breast cancer studies ...